Long-term coexistence of Pseudomonas aeruginosa and Staphylococcus aureus using an in vitro cystic fibrosis model

Future Microbiol. 2021 Aug:16:879-893. doi: 10.2217/fmb-2021-0025. Epub 2021 Jul 28.

Abstract

Aim: To investigate the role of pre-established Staphylococcus aureus on Pseudomonas aeruginosa adaptation and antibiotic tolerance. Materials & methods: Bacteria were cultured mimicking the sequential pattern of lung colonization and exposure to ciprofloxacin. Results: In the absence of ciprofloxacin exposure, S. aureus and P. aeruginosa coexisted supported by the physicochemical characteristics of the artificial sputum medium. S. aureus had no role in P. aeruginosa tolerance against ciprofloxacin and did not select P. aeruginosa small-colony variants during antibiotic treatment. rhlR and psqE were downregulated after the contact with S. aureus indicating that P. aeruginosa attenuated its virulence potential. Conclusion:P. aeruginosa and S. aureus can cohabit in cystic fibrosis airway environment for long-term without significant impact on P. aeruginosa adaptation and antibiotic tolerance.

Keywords: Pseudomonas aeruginosa; Staphylococcus aureus; coexistence; cystic fibrosis; in vitro sequential growth; interspecies interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Ciprofloxacin / pharmacology
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / microbiology
  • Drug Resistance, Bacterial*
  • Humans
  • Pseudomonas Infections
  • Pseudomonas aeruginosa*
  • Staphylococcal Infections
  • Staphylococcus aureus*
  • Virulence

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin